Veau III and Veau IV cleft palate Surgery
Conditions
Interventions
Alveolar repair through iliac bone graft took place as warranted at 8-11 years of age to accommodate canine eruption and development, along with premaxillary repositioning osteotomy of bilateral compl
Baxter AG, Vienna, Austria) was applied at times (not routinely) below the repaired nasal layer (Vicryl 5-0
Ethicon, Somerville, NJ, USA) and stabilized by adding fibrin sealant (Tisseel
Baxter). Bone marrow was aspirated from the iliac crest using a 50-mm Jamshidi needle (Handlex
Medax, Poggio Rusco, Italy). Cancellous bone was harvested through a medially based trap-door technique from the anterior iliac crest (Video) with the use of Champy 8 mm and 5 mm Bone Biopsy Instrumen
afterwards, was syringe-condensed into the alveolar cleft and manually molded. After suturing of oral mucosa (Vicryl 4/0), fibrin sealant was employed to affix the mucoperiosteal flaps onto the transp
First Aid Bandage Company, New London, CT, USA) was inserted and remained in place until hospital discharge (average, 2 days). At the donor site, a continuous anesthetic elastomeric pump (Baxter Inter
Sponsors
Universitair Ziekenhuis Brussel
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: All cleft patients receiving secondary alveolar bone grafts between 1991 and 2020 were reviewed
Exclusion criteria
Exclusion criteria: 1. Lost to follow-up 2. Incomplete files
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Success rate of autogenous mid-secondary alveolar bone grafting assessed using patient charts from between 1990 and 2020. Criteria for success were: long-term preservation of alveolar bone stock, ability of spontaneous or orthodontic-guided eruption and periodontal health of permanent lateral incisors and canine teeth, absence of exposed root structures for teeth adjacent to clefts, absence of fistula and successful placement of osseointegrated implants as warranted. Failure of alveolar bone grafts was indicated by radiographically demonstrable total or near-total graft loss requiring reintervention. | — |
Secondary
| Measure | Time frame |
|---|---|
| There were no secondary outcome measures | — |
Countries
Belgium
Outcome results
None listed